Literature DB >> 12103367

Lung surgery: identifying the subgroup at risk for sputum retention.

Pramod Bonde1, Kieran McManus, Martin McAnespie, Jim McGuigan.   

Abstract

OBJECTIVES: Sputum retention after lung surgery is a potentially lethal condition, which can progress to atelectasis, pneumonia and respiratory failure requiring ventilatory support. Previous studies have concentrated on the treatment of postoperative respiratory complications but few have studied the risk factors for sputum retention. This prospective study was designed to identify the risk factors which may lead to the development of sputum retention after lung surgery.
METHODS: Three hundred sixty-one patients underwent lung surgery between January 1997 and December 1999 in a specialist Thoracic Surgery Unit (pneumonectomy, lobectomy, wedge or segmental resection, bullectomy, etc). Preoperative and intraoperative data collected prospectively included potential risk factors: chronic obstructive airway disease (COAD), forced expiratory volume in 1 s (FEV1)<50%, current smokers, ischaemic heart disease (IHD), cerebrovascular disease (CVA), resection of phrenic or recurrent laryngeal nerve, or absence of regional analgesia. Univariate and multivariate analysis was performed.
RESULTS: Sputum related complications occurred in 108 patients (30%). There were 17 deaths of which nine were due to complications related to sputum retention. Univariate analysis confirmed current smokers (n=128), COAD (n=103), IHD (n=41), prior history of CVA (n=16), FEV1<50% (n=48), and absence of regional anaesthesia as significant risk factors (P<0.01). The multivariate analysis confirmed current smokers, IHD and absence of regional anaesthesia as risk factors.
CONCLUSIONS: A subgroup of lung surgery patients at high risk for postoperative sputum retention can be predicted by the presence of one of the following criteria: current smokers, history of COAD, CVA, or IHD, and absence of regional analgesia. Prophylactic measures should be considered in this group to reduce the incidence of sputum retention.

Entities:  

Mesh:

Year:  2002        PMID: 12103367     DOI: 10.1016/s1010-7940(02)00205-1

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

Review 1.  Postlobectomy Early Complications.

Authors:  Elena Ziarnik; Eric L Grogan
Journal:  Thorac Surg Clin       Date:  2015-06-12       Impact factor: 1.750

2.  Multidisciplinary Evaluation of Patients With Suspected Lung Cancer.

Authors:  Kristy Bauman; Douglas Arenberg
Journal:  Clin Pulm Med       Date:  2010-01-01

3.  Predictors of atelectasis after pulmonary lobectomy.

Authors:  Alan J Stolz; Jan Schutzner; Robert Lischke; Jan Simonek; Tomas Harustiak; Pavel Pafko
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

4.  A nurse-driven enhanced recovery after surgery (ERAS) nursing program for geriatric patients following lung surgery.

Authors:  Yan Li; Chuanchuan Yan; Jing Li; Qiujing Wang; Jing Zhang; Wanmin Qiang; Daliang Qi
Journal:  Thorac Cancer       Date:  2020-03-02       Impact factor: 3.500

5.  Active cycle of breathing technique may reduce pulmonary complications after esophagectomy: A randomized clinical trial.

Authors:  Jiudi Zhong; Siwen Zhang; Chuangzhen Li; Yi Hu; Weijin Wei; Li Liu; Ming Wang; Zhangxian Hong; Hao Long; Tiehua Rong; Hong Yang; Xiaodong Su
Journal:  Thorac Cancer       Date:  2021-11-12       Impact factor: 3.500

6.  [Severity Factors of Pulmonary Aspergilloma in the Surgical Intensive Care Unit of Joseph Ravoahangy Andrianavalona Hospital, Antananarivo, Madagascar].

Authors:  N N M Razafimanjato; J M Rakotoson; M Ravoatrarilandy; R L Andrianasolo; A T Rajaonera; N E Raveloson; H J L Rakotovao
Journal:  Med Trop Sante Int       Date:  2021-02-18

7.  Clinical value of a prophylactic minitracheostomy after esophagectomy: analysis in patients at high risk for postoperative pulmonary complications.

Authors:  Yayoi Sakatoku; Masahide Fukaya; Kazushi Miyata; Keita Itatsu; Masato Nagino
Journal:  BMC Surg       Date:  2017-12-01       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.